We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

BioSante Reports 100% Protection from H1N1 Challenge When Using BioVant™ Adjuvanted Vaccine

News   Aug 18, 2009

 
BioSante Reports 100% Protection from H1N1 Challenge When Using BioVant™ Adjuvanted Vaccine
 
 
 

RELATED ARTICLES

Structure Discovered Which Mediates Cell-matrix Attachment During Mitosis

News

The newly discovered adhesion complex can provide answers to an as-yet unanswered question – how the cell can remain attached to the matrix during cell division.

READ MORE

Curing Drug-Resistant Infections Without Antibiotics

News

Biochemists, microbiologists, drug discovery experts and infectious disease doctors have teamed up in a new study that shows antibiotics are not always necessary to cure sepsis in mice. Instead of killing causative bacteria with antibiotics, researchers treated infected mice with molecules that block toxin formation in bacteria.

READ MORE

Treatment Eliminates Nicotine Addiction in Preclinical Tests

News

Scientists at Scripps Research have successfully tested a potential new smoking-cessation treatment in rodents.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE